Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Digestive Enzymes as Add on Therapy on Patients With Functional Dyspepsia
NCT07578402Phase 4Not yet recruiting
- Sponsor
- Rakibul Mostafa
- Start
- May 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in functional dyspepsia (FD) (2 arms), sponsored by Rakibul Mostafa. Primary endpoint: Change in dyspeptic symptom at 4 weeks. Planned start May 2026; status: not yet recruiting.
02
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT07578402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07578402.